Haemonetics Operating Expenses 2010-2025 | HAE

Haemonetics operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Haemonetics Annual Operating Expenses
(Millions of US $)
2025 $1,139
2024 $1,144
2023 $1,013
2022 $912
2021 $781
2020 $885
2019 $884
2018 $848
2017 $905
2016 $953
2015 $870
2014 $892
2013 $836
2012 $639
2011 $566
2010 $562
2009 $512
Haemonetics Quarterly Operating Expenses
(Millions of US $)
2025-06-30 $268
2025-03-31 $259
2024-12-31 $290
2024-09-30 $294
2024-06-30 $296
2024-03-31 $313
2023-12-31 $290
2023-09-30 $283
2023-06-30 $258
2023-03-31 $269
2022-12-31 $262
2022-09-30 $251
2022-06-30 $231
2022-03-31 $246
2021-12-31 $224
2021-09-30 $215
2021-06-30 $227
2021-03-31 $246
2020-12-31 $200
2020-09-30 $151
2020-06-30 $184
2020-03-31 $212
2019-12-31 $218
2019-09-30 $203
2019-06-30 $252
2019-03-31 $225
2018-12-31 $219
2018-09-30 $216
2018-06-30 $224
2018-03-31 $219
2017-12-31 $233
2017-09-30 $201
2017-06-30 $194
2017-03-31 $286
2016-12-31 $207
2016-09-30 $195
2016-06-30 $218
2016-03-31 $248
2015-12-31 $295
2015-09-30 $201
2015-06-30 $210
2015-03-31 $215
2014-12-31 $214
2014-09-30 $215
2014-06-30 $226
2014-03-31 $229
2013-12-31 $224
2013-09-30 $212
2013-06-30 $226
2013-03-31 $232
2012-12-31 $232
2012-09-30 $208
2012-06-30 $163
2012-03-31 $166
2011-12-31 $166
2011-09-30 $161
2011-06-30 $147
2011-03-31 $141
2010-12-31 $148
2010-09-30 $138
2010-06-30 $139
2010-03-31 $165
2009-12-31 $139
2009-09-30 $130
2009-06-30 $128
2009-03-31 $134
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.716B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.767B 27.06
Boston Scientific (BSX) United States $157.318B 37.52
Stryker (SYK) United States $150.713B 30.68
EssilorLuxottica (ESLOY) France $147.808B 0.00
Medtronic (MDT) Ireland $118.836B 16.76
Lonza Group Ag (LZAGY) Switzerland $49.610B 0.00
Haleon (HLN) United Kingdom $44.040B 25.18
ResMed (RMD) United States $43.006B 30.76
Agilent Technologies (A) United States $34.551B 22.52
GE HealthCare Technologies (GEHC) United States $34.343B 16.14
Terumo (TRUMY) Japan $27.701B 32.83
Koninklijke Philips (PHG) Netherlands $27.289B 18.05
Insulet (PODD) United States $23.284B 78.01
Zimmer Biomet Holdings (ZBH) United States $21.337B 13.58
Smith & Nephew SNATS (SNN) United Kingdom $16.420B 0.00
Baxter (BAX) United States $12.604B 9.74
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Bio-Rad Laboratories (BIO) United States $8.222B 30.20
Demant (WILYY) Denmark $8.121B 0.00
Lantheus Holdings (LNTH) United States $3.958B 10.70
Envista Holdings (NVST) United States $3.609B 25.26
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.369B 8.42
Prestige Consumer Healthcare (PBH) United States $3.283B 14.57
ICU Medical (ICUI) United States $3.164B 21.54
LeMaitre Vascular (LMAT) United States $2.271B 48.70
Acuren (TIC) United States $2.108B 0.00
QuidelOrtho (QDEL) United States $1.894B 11.92
Curaleaf Holdings (CURLF) Canada $1.891B 0.00
AtriCure (ATRC) United States $1.872B 0.00
Green Thumb Industries (GTBIF) United States $1.757B 75.46
Phibro Animal Health (PAHC) United States $1.316B 16.82
AdaptHealth (AHCO) United States $1.300B 18.48
Tilray Brands (TLRY) Canada $1.266B 0.00
BioLife Solutions (BLFS) United States $1.241B 2591.00
Neogen (NEOG) United States $1.225B 19.45
Valneva SE (VALN) France $0.990B 0.00
Kestra Medical Technologies (KMTS) United States $0.954B 0.00
InMode (INMD) Israel $0.936B 8.66
Maravai LifeSciences Holdings (MRVI) United States $0.626B 0.00
Cresco Labs (CRLBF) United States $0.607B 0.00
SNDL (SNDL) Canada $0.591B 0.00
Verano Holdings (VRNOF) United States $0.561B 0.00
ZimVie (ZIMV) United States $0.534B 20.60
Surmodics (SRDX) United States $0.532B 0.00
Evolus (EOLS) United States $0.497B 0.00
VAREX IMAGING (VREX) United States $0.482B 16.60
CeriBell (CBLL) United States $0.442B 0.00
Owens & Minor (OMI) United States $0.390B 3.46
Sanuwave Health (SNWV) United States $0.386B 0.00
Capricor Therapeutics (CAPR) United States $0.325B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
TerrAscend (TSNDF) Canada $0.306B 0.00
Canopy Growth (CGC) Canada $0.305B 0.00
Sanara MedTech (SMTI) United States $0.302B 0.00
Omeros (OMER) United States $0.299B 0.00
High Tide (HITI) Canada $0.290B 0.00
Brainsway (BWAY) Israel $0.287B 58.46
Viemed Healthcare (VMD) United States $0.284B 21.50
Aurora Cannabis (ACB) Canada $0.282B 0.00
TriSalus Life Sciences (TLSI) United States $0.252B 0.00
Cerus (CERS) United States $0.243B 0.00
Vireo Growth (VREOF) United States $0.241B 0.00
Quanterix (QTRX) United States $0.224B 0.00
Exagen (XGN) United States $0.222B 0.00
OraSure Technologies (OSUR) United States $0.219B 0.00
Organigram Global (OGI) Canada $0.214B 0.00
Utah Medical Products (UTMD) United States $0.195B 16.30
FitLife Brands (FTLF) United States $0.160B 0.00
Biote (BTMD) United States $0.159B 5.28
Jushi Holdings (JUSHF) United States $0.133B 0.00
Jin Medical (ZJYL) China $0.113B 0.00
MacroGenics (MGNX) United States $0.107B 0.00
Fonar (FONR) United States $0.095B 12.19
Quipt Home Medical (QIPT) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Safety Shot (SHOT) United States $0.070B 0.00
Agape ATP (ATPC) $0.066B 0.00
Cytosorbents (CTSO) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.055B 32.07
Veru (VERU) United States $0.053B 0.00
Zynex (ZYXI) United States $0.050B 0.00
Nephros (NEPH) United States $0.044B 34.83
Modular Medical (MODD) United States $0.040B 0.00
Rockwell Medical (RMTI) United States $0.039B 0.00
United-Guardian (UG) United States $0.038B 14.95
Trinity Biotech (TRIB) Ireland $0.028B 0.00
Senestech (SNES) United States $0.023B 0.00
INLIF (INLF) $0.018B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Sharps Technology (STSS) United States $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00